Document is current
Any future updates will be listed below
-
Authors
Sawada, Keisuke
Inose, Ryo
Muraki, Yuichi
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (23K09539)
- License Information
-
More Information
Article History
Received: 11 December 2025
Accepted: 20 February 2026
First Online: 26 February 2026
Declarations
:
: This study was approved by the Kyoto Pharmaceutical University Ethics Committee (exemption number: NR-00006). The requirement for individual informed consent was waived because the database consists of fully anonymized data.
: Not applicable.
: RI received funding for commissioned research from Kowa Company, Ltd. YM received grants from Pfizer Japan Inc., Kowa Company Ltd., the Japan Pharmaceutical Association, and the Ministry of Health, Labor and Welfare. YM is a board member of the Japanese Society of Pharmaceutical Health Care and Sciences and the Japanese Society for Infection Prevention and Control and a committee member of the AMR Clinical Reference Center. The authors declare that they have no other competing interests.
